ALDH3A2 | Aldehyde dehydrogenase 3 family, member A2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ALG10 | ALG10, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins
| | | | | Mixed |
ALG10B | ALG10B, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO10 | Anoctamin 10 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APOO | Apolipoprotein O | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
AQP7 | Aquaporin 7 | Predicted membrane proteins
| | | | | Tissue enhanced |
ARIH2OS | Ariadne homolog 2 opposite strand | Predicted membrane proteins
| | | | | Mixed |
ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
ARSH | Arylsulfatase family, member H | Predicted membrane proteins
| | | | | Not detected |
ARV1 | ARV1 homolog (S. cerevisiae) | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ASIC1 | Acid-sensing (proton-gated) ion channel 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ASIC2 | Acid-sensing (proton-gated) ion channel 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASIC3 | Acid-sensing (proton-gated) ion channel 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
ASIC4 | Acid-sensing (proton-gated) ion channel family member 4 | Predicted membrane proteins
| | | | | Group enriched |
ASIC5 | Acid-sensing (proton-gated) ion channel family member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
ASTN1 | Astrotactin 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASTN2 | Astrotactin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATG9A | Autophagy related 9A | Predicted membrane proteins
| | | | | Expressed in all |
ATG9B | Autophagy related 9B | Predicted membrane proteins
| | | | | Tissue enhanced |
ATL1 | Atlastin GTPase 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ATL2 | Atlastin GTPase 2 | Predicted membrane proteins
| | | | | Expressed in all |
ATL3 | Atlastin GTPase 3 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ATP11A | ATPase, class VI, type 11A | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP11B | ATPase, class VI, type 11B | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A3 | ATPase type 13A3 | Predicted membrane proteins
| | | | | Expressed in all |
ATP13A4 | ATPase type 13A4 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATP2A3 | ATPase, Ca++ transporting, ubiquitous | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP5G1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP5G2 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6V0B | ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b | Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0E1 | ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 | Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0E2 | ATPase, H+ transporting V0 subunit e2 | Predicted membrane proteins
| | | | | Expressed in all |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP8B3 | ATPase, aminophospholipid transporter, class I, type 8B, member 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |